Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Sloan

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
ACP Journal Club|November 4, 2006
Clopidogrel plus aspirin was inferior to oral anticoagulation for preventing vascular events in atrial fibrillationMichael A Sloan
American Heart Journal|January 6, 2005
The continuing importance of prior stroke in STEMI patientsMichael A Sloan
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|March 19, 2009
Current issues in neuroimagingMichael A Sloan
Annals of Internal Medicine|February 25, 2009
ACP Journal Club. Aspirin plus extended-release dipyridamole and clopidogrel were similarly effective for preventing recurrent strokeMichael A Sloan
Evidence-Based Medicine|April 1, 2009
Telmisartan did not prevent recurrent stroke or major cardiovascular eventsMichael A Sloan
Evidence-Based Medicine|April 1, 2009
Aspirin plus extended-release dipyridamole and clopidogrel were similarly effective for preventing recurrent strokeMichael A Sloan
Stroke|July 10, 2002
Diagnosis of basilar artery vasospasmMichael A Sloan
Neurologic Clinics|August 29, 2006
Prevention of ischemic neurologic injury with intraoperative monitoring of selected cardiovascular and cerebrovascular procedures: roles of electroencephalography, somatosensory evoked potentials, transcranial Doppler, and near-infrared spectroscopyMichael A Sloan
Annals of Internal Medicine|February 25, 2009
ACP Journal Club. Telmisartan did not prevent recurrent stroke or major cardiovascular eventsMichael A Sloan
Evidence-Based Medicine|January 11, 2007
Clopidogrel plus aspirin was inferior to oral anticoagulation for preventing vascular events in atrial fibrillationMichael A Sloan
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
ACP Journal Club|November 4, 2006
Clopidogrel plus aspirin was inferior to oral anticoagulation for preventing vascular events in atrial fibrillationMichael A Sloan
American Heart Journal|January 6, 2005
The continuing importance of prior stroke in STEMI patientsMichael A Sloan
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|March 19, 2009
Current issues in neuroimagingMichael A Sloan
Annals of Internal Medicine|February 25, 2009
ACP Journal Club. Aspirin plus extended-release dipyridamole and clopidogrel were similarly effective for preventing recurrent strokeMichael A Sloan
Evidence-Based Medicine|April 1, 2009
Telmisartan did not prevent recurrent stroke or major cardiovascular eventsMichael A Sloan
Evidence-Based Medicine|April 1, 2009
Aspirin plus extended-release dipyridamole and clopidogrel were similarly effective for preventing recurrent strokeMichael A Sloan
Stroke|July 10, 2002
Diagnosis of basilar artery vasospasmMichael A Sloan
Neurologic Clinics|August 29, 2006
Prevention of ischemic neurologic injury with intraoperative monitoring of selected cardiovascular and cerebrovascular procedures: roles of electroencephalography, somatosensory evoked potentials, transcranial Doppler, and near-infrared spectroscopyMichael A Sloan
Annals of Internal Medicine|February 25, 2009
ACP Journal Club. Telmisartan did not prevent recurrent stroke or major cardiovascular eventsMichael A Sloan
Evidence-Based Medicine|January 11, 2007
Clopidogrel plus aspirin was inferior to oral anticoagulation for preventing vascular events in atrial fibrillationMichael A Sloan
Pageof 4